CTKB

CTKB EBITDA Margin

-13.14%TTM

Period ending:

CTKB FY EBITDA Margin%
CTKB FY EBITDA Margin21.85%-32.91%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CTKB ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Cytek Biosciences Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-8.6316%
2.3896%
-2.2838%
5.7865%
6.9723%
16.5512%
-27.6143%

Compare ebitda margin

All CTKB financial metrics · CTKB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.